Equities researchers at Wells Fargo & Company started coverage on shares of Versigent (NYSE:VGNT – Get Free Report) in a research report issued to clients and investors on Monday,Benzinga reports. The firm set an “overweight” rating and a $35.00 price target on the stock.
Separately, Royal Bank Of Canada began coverage on shares of Versigent in a report on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 price objective for the company. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $31.50.
Read Our Latest Report on Versigent
Versigent Stock Performance
Read More
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
